Efectos secundarios y seguridad: Los eventos adversos se parecen a otros agonistas incretnicos, predominando sntomas gastrointestinales: nuseas, diarrea, vmitos, estreimiento, disminucin del apetito y malestar estomacal, con dependencia de dosis
PS-MPs increased the levels of inflammatory markers, including IL-1, IL-1, and intracellular adhesion molecule-1 (ICAM-1) in both myocardial tissue and serum, and decreased the IL-6 expression level in the myocardial tissue of rats
The other has a human trial that missed its endpoint and a larger one that was never published
Am J Chin Med 41(03):503513 Boccardi V, Tinarelli C, Mecocci P (2017) Nutraceuticals and cognitive dysfunction: focus on Alzheimers disease
in 1994 [6]